At the end of the modelling period, PCOS-like serological alterations were confirmed by elevated luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratios (p = 0.0129) and increased testosterone levels (p = 0.0390) (Figure 1D). The gene discussed is PLOD1; the disease is polycystic ovary syndrome.